Therapy News and Research

RSS

Study: Peripheral nerve stimulation therapy can reverse SCI-associated nerve deterioration

Approximately 12,000 spinal cord injuries (SCI) happen every year in the U.S., the majority caused by car accidents, falls, sporting accidents and gunshot wounds.

2 Jul 2015

Premature babies who avoid eye contact in early infancy less likely to show symptoms of autism

Premature babies are at an increased risk for developing autism spectrum disorder. But a small study indicates that preemies who avoid eye contact in early infancy are less likely to demonstrate symptoms of autism at age 2 than preemies who maintain eye contact during early interactions, according to new research at Washington University School of Medicine in St. Louis.

2 Jul 2015

Frequent consumption of citrus fruits may increase risk of skin cancer

A new analysis of dietary patterns among more than 100,000 Americans suggests that frequent consumption of citrus -- namely whole grapefruit and orange juice -- may be associated with an increased risk of melanoma.

2 Jul 2015

Concert Pharmaceuticals’ precision deuteration platform can enhance metabolic properties of drugs

Substituting deuterium for certain hydrogen atoms in molecules has been shown to enhance the metabolic properties of a number of drugs and provides a promising approach to the discovery and development of innovative drug products.

2 Jul 2015

Low BMI linked to poorer survival in advanced colorectal cancer

Although being overweight with a high body-mass index (BMI) has long been associated with a higher risk for colorectal cancer, thinner patients might not fare as well after treatment for advanced cancer, according to a new study from Duke Medicine.

2 Jul 2015

Two-thirds of patients with T4a larynx cancer not receiving total laryngectomy

Despite findings of previous studies and published guidelines, nearly two-thirds of patients with T4a larynx ("voice box") cancer are not receiving a total laryngectomy (surgical removal of the larynx), the recommended form of treatment, and as a result, have significantly worse survival rates versus those treated with a total laryngectomy, a new study published in the International Journal of Radiation Oncology, Biology and Physics by experts at Penn Medicine found.

2 Jul 2015

Researchers complete phase 1 clinical trial of new drug for children suffering from neuroblastoma

Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.

2 Jul 2015

Dynatronics completes $4,025,000 private placement financing

Dynatronics Corporation, a manufacturer and marketer of rehabilitation and physical therapy products, announced today that it has completed its $4,025,000 private placement financing led by affiliates of Prettybrook Partners LLC (collectively, "Prettybrook"), a strategic private equity investor focused on the healthcare industry.

1 Jul 2015

Robert G. Miller awarded $1.5 million grant to help fund Neuraltus' Phase 2 clinical study of NP001 for ALS

Neuraltus Pharmaceuticals, Inc., a privately-held biopharmaceutical company focused on the development of groundbreaking drugs to treat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), announced today that Robert G. Miller, M.D., Director of the Forbes Norris MDA/ALS Research Center at Sutter Health's California Pacific Medical Center in San Francisco, has been awarded a grant from The ALS Association for $1.5 million to help fund a Phase 2 clinical study of the company's investigational therapy for ALS, NP001.

1 Jul 2015

ALS ACT initiative to speed discovery of new ALS treatments

The ALS Association and the ALS Finding a Cure Foundation are pleased to announce $3 million in funding for two new Phase II clinical studies through the ALS Accelerated Therapeutics (ALS ACT) initiative.

1 Jul 2015

Virtual human helps veterans with PTSD, people with mental illness build job interview skills

Finding a job is difficult for veterans with posttraumatic stress disorder (PTSD) and individuals with severe mental illness, who have high unemployment rates even though many want to work.

1 Jul 2015

New collection of papers adds to mounting evidence of gut microbiome’s influential role in health

A newly released collection of papers, the result of the Gut in Focus Symposium Nobel Forum held earlier this year, is adding to the mounting evidence of the influential role the gut microbiome plays in health.

1 Jul 2015

Subcutaneous administration increases tolerability of multispecific antibody tumor treatment

Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. This was the result of an animal model study undertaken by researchers at Helmholtz Zentrum München in cooperation with the Munich biotech company Trion Research.

1 Jul 2015

Express Scripts report shows that new exchange plan enrollees spent less on medications in Q1 2015

New exchange plan enrollees spent less on medications in the first quarter of 2015 compared to the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report, released today.

1 Jul 2015

Implantable microfluid system can efficiently stabilize intraocular pressure

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, Fraunhofer researchers are developing an implantable microfluid system that can efficiently and durably stabilize intraocular pressure.

1 Jul 2015

Damon Runyon creates new award to increase number of physician-scientists

Physician-scientists are crucial to moving scientific discoveries from the lab to patients, but their numbers have been dwindling just when they are needed most, particularly in cancer research, as the number of cancer cases is projected to increase by 45 percent in the next fifteen years and elevate cancer to the leading cause of death in America.

1 Jul 2015

Researchers use pioneering stem cell techniques to better understand causes of Spinal Muscular Atrophy

New research from the Advanced Gene and Cell Therapy Lab at Royal Holloway, University of London has used pioneering stem cell techniques to better understand why certain cells are more at risk of degenerating in Spinal Muscular Atrophy than others.

1 Jul 2015

UVA Health System opens high-tech clinical genomics lab

The University of Virginia Health System has opened a high-tech clinical genomics lab that will personalize care for patients, help doctors determine the best treatments for cancers and other diseases, and allow UVA to offer the most cutting-edge clinical trials.

1 Jul 2015

Benefit and harm of vision screening in preschool-aged children still unclear

It remains unclear whether a special ophthalmological examination of all children younger than 6 years (and potential follow-up treatments) would reduce the frequency and severity of visual impairment (amblyopia) in the population. An update search conducted for a benefit assessment of the German Institute for Quality and Efficiency in Health Care from 2008 identified no new screening study.

1 Jul 2015

NIBIB-supported researchers create platelet-like particles to control excessive bleeding, augment clotting

NIBIB-supported researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy.

1 Jul 2015

Therapy News and Research

Study: Peripheral nerve stimulation therapy can reverse SCI-associated nerve deterioration

Premature babies who avoid eye contact in early infancy less likely to show symptoms of autism

Frequent consumption of citrus fruits may increase risk of skin cancer

Concert Pharmaceuticals’ precision deuteration platform can enhance metabolic properties of drugs

Low BMI linked to poorer survival in advanced colorectal cancer

Two-thirds of patients with T4a larynx cancer not receiving total laryngectomy

Researchers complete phase 1 clinical trial of new drug for children suffering from neuroblastoma

Dynatronics completes $4,025,000 private placement financing

Robert G. Miller awarded $1.5 million grant to help fund Neuraltus' Phase 2 clinical study of NP001 for ALS

ALS ACT initiative to speed discovery of new ALS treatments

Virtual human helps veterans with PTSD, people with mental illness build job interview skills

New collection of papers adds to mounting evidence of gut microbiome’s influential role in health

Subcutaneous administration increases tolerability of multispecific antibody tumor treatment

Express Scripts report shows that new exchange plan enrollees spent less on medications in Q1 2015

Implantable microfluid system can efficiently stabilize intraocular pressure

Damon Runyon creates new award to increase number of physician-scientists

Researchers use pioneering stem cell techniques to better understand causes of Spinal Muscular Atrophy

UVA Health System opens high-tech clinical genomics lab

Benefit and harm of vision screening in preschool-aged children still unclear

NIBIB-supported researchers create platelet-like particles to control excessive bleeding, augment clotting

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News